Have you ever seen a hibiscus flower? Although its petals have a range of colors, what makes the trumpet-shaped flower more ...

The company expects to expand global distributor agreements to cover over 40 countries in 2026 and to finalize VYJUVEK pricing and launch in Italy in the second half of 2026. Management reaffirmed ...

When touring Tufts, prospective students often hear that the university is home to over 300 student organizations, and that students are welcome to create their own if they do not see their interests ...

Triphine Mukandanga, a potato farmer in Cyanika Sector, Burera District, describes the 2026 planting season as a difficult one that has left her questioning whether to continue with the crop after ...

As global drugmakers cut costs before patents expire, they are increasing their search for China's experimental medicines.

Capcom and biotech art group LOM BABY bring Resident Evil’s T-virus to Shibuya PARCO, explaining the exhibit, safety claims, and real biotech context ...

In an era of escalating biological threats, from weaponized pathogens to evolving viruses like Mpox, small U.S. biotechs are stepping up to bolster military readiness and national security.

Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain Moderna's narrower-than-expected loss, why healthcare is outperforming, and vaccine mandates and ...

Arthur Herman’s op-ed, “America Is the Sole Superpower Again,” (Jan. 15) asserts that China is “sliding into a distant second place” in the battle for economic, military and technological supremacy.

To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in ...

Donald Trump reveals plan to tackle energy bills for millions Healthiest red meats to eat — and how a cardiologist says to prepare them Aaron Rodgers on criticism of Steelers HC Mike Tomlin: 'That's ...